T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors-Reference-Cited by-同舟云学术

T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors

Published:2019-07-25 Issue:11 Volume:8 Page:e1644110
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Simnica Donjete¹,Akyüz Nuray²,Schliffke Simon²,Mohme Malte³,v.Wenserski Lisa¹,Mährle Thorben²,Fanchi Lorenzo F.⁴,Lamszus Katrin³,Binder Mascha¹

Affiliation:

1. Department of Internal Medicine IV, Oncology/Hematology, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany

2. Department of Oncology and Hematology, BMT with section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

3. Department of Neurosurgery, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany

4. ENPICOM B.V., ‘s-Hertogenbosch, The Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1644110

Reference23 articles.

1. Causes, consequences, and reversal of immune system aging

2. Evolution of the immune system in humans from infancy to old age

3. The development of T cells from stem cells in mice and humans

4. Lymphocyte generation and population homeostasis throughout life

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NKp44/HLA-DP-dependent regulation of CD8 effector T cells by NK cells;Cell Reports;2024-04

2. Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab – the randomized phase 2 FOCUS trial;Frontiers in Oncology;2024-02-07

3. Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma;JAMA Network Open;2024-01-23

4. Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma;Cancer Research Communications;2023-10-20

5. Distinguishing COVID-19 from seasonal influenza in patients under age 65 years—a retrospective observational cohort study comparing the 2009 influenza A (H1N1) and 2022 SARS-CoV-2 pandemics;Frontiers in Cellular and Infection Microbiology;2023-07-18